Masanari Shiramoto
Hakata-ekimae, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan-Approved Humalog Insulin Lispro in Healthy Japanese Subjects.
Journal: Clinical pharmacology in drug development
Published: October 08, 2021
Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects.
Journal: Scientific reports
Published: June 10, 2021
Comparison of Pharmacokinetic Profiles of Beraprost Sustained Release in Japanese, Chinese, and Korean Healthy Adult Males.
Journal: Clinical drug investigation
Published: March 22, 2021
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects.
Journal: BMC pharmacology & toxicology
Published: January 15, 2020
Effects of itraconazole and rifampicin on the single-dose pharmacokinetics of the nonsteroidal mineralocorticoid receptor blocker esaxerenone in healthy Japanese subjects.
Journal: British journal of clinical pharmacology
Published: November 21, 2019
Levocetirizine Oral Disintegrating Tablet: A Randomized Open-Label Crossover Bioequivalence Study in Healthy Japanese Volunteers.
Journal: Clinical pharmacology in drug development
Published: September 24, 2019
Ultra-Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes.
Journal: Journal of diabetes investigation
Published: July 05, 2019
Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 23, 2019
Response to Comments on "Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study".
Journal: Clinical drug investigation
Published: January 12, 2019
Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus.
Journal: Clinical pharmacokinetics
Published: November 08, 2018
Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study.
Journal: Clinical drug investigation
Published: September 01, 2018
Safety, Tolerability, and Pharmacokinetics of NK-104-NP.
Journal: International heart journal
Published: August 31, 2018
Last Updated: 09/26/2026